Announcements

ADDF and Harrington Discovery Institute Announce 2015 Award Recipients

08/26/2015

Collaboration Advances Development of Therapeutics for the Treatment of Alzheimer’s Disease

ADDF to be Featured in Upcoming Episode of Innovations with Ed Begley Jr.

08/24/2015

The ADDF will be featured in an upcoming episode of Innovations with Ed Begley Jr., airing via Discovery Channel later this year. 

Goodes Family & The ADDF Create New Prize for Alzheimer’s Drug Development Researchers

08/12/2015

Melvin R. Goodes Prize Supports Innovative Projects by Top Researchers While Honoring Pioneering Legacy of Former Warner-Lambert CEO 

Carmel Valley, California Winery Launches Two New Wines to Benefit the ADDF

08/06/2015

Carmel Valley's newest winery, Jarman Wines, will introduce two premium varietals to benefit the Alzheimer's Drug Discovery Foundation (ADDF) and to honor the matriarch of the family whose name graces the wines created for her.

Grantees at Lou Rovo Center for Brain Health Recruiting for New Alzheimer’s Disease Trial

07/30/2015

Cleveland Clinic Lou Ruvo Center for Brain Health is now recruiting participants for a new, multicenter Alzheimer’s disease (AD) treatment trial, Rasagiline Rescue (R2), which is designed to determine if treatment with rasagiline is associated with improved brain glucose metabolism and improvement in memory.

Adam Rowe Reflects: A Mother’s Voice

05/08/2015

A mother's voice is the first thing we hear from the time we exit the womb. And its the voice we continue to hear throughout our lives. We model our mother's voice when we first learn to talk. The same voice guides us as we begin to walk. It warns you of potential harm and radiates warmth when you need consolation.

Alzheimer’s Drug Discovery Foundation Connoisseur’s Dinner Raises $2.8 Million

05/04/2015

On Monday, April 27, 2015, American theatre director, choreographer, film director and performer Susan Stroman hosted the Alzheimer’s Drug Discovery Foundation’s (ADDF) Ninth Annual Connoisseur’s Dinner at Sotheby’s in New York City. Co-chaired by Leonard A. Lauder of the Estée Lauder cosmetics family, the black-tie event featured fine wine, food and art. More than $2.8 million was raised to support Alzheimer's drug discovery and development 

Diane Rehm Hosts 2015 Great Ladies Luncheon & Fashion Show

04/17/2015

On Wednesday, April 15, 2015, renowned journalist and NPR host Diane Rehm welcomed guests to the Alzheimer’s Drug Discovery Foundation’s (ADDF) Fifth Annual Great Ladies Luncheon & Fashion Show at The Ritz-Carlton in Washington, DC. Rehm, who has long used her public platform to raise awareness for Alzheimer’s disease, spoke eloquently about the need to increase support for drug discovery for Alzheimer’s. She also expressed hope for the future, noting that “there are hundreds of new, potentially disease-modifying drugs in the pipeline.”

Asceneuron Awarded Alzheimer’s Drug Discovery Foundation Grant

04/09/2015

Asceneuron SA, an emerging leader in the development of novel, oral small molecule therapeutics targeting tauopathies for Alzheimer’s and related neurodegenerative diseases, today announced that the Alzheimer’s Drug Discovery Foundation (ADDF) awarded it a $325,000 grant to support the development of Asceneuron’s tau modulators.

GliaCure Receives $1 Million Grant for Alzheimer’s Clinical Trial

03/17/2015

The Alzheimer’s Drug Discovery Foundation (ADDF) announced today that it has awarded $1 million to GliaCure, a biotechnology company developing innovative therapies based on glial targets, to co-fund a Phase 1b clinical trial in patients with mild to moderate Alzheimer’s disease. The study, which recently began screening volunteers, will determine the safety and tolerability of GliaCure’s primary clinical candidate, GC021109. It follows a 2014 Phase 1a trial which showed GC021109 to be safe and well tolerated in healthy volunteers.

Go to top